Detalhe da pesquisa
1.
Vaccinology in the post-COVID-19 era.
Proc Natl Acad Sci U S A
; 118(3)2021 01 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33431690
2.
H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.
J Clin Immunol
; 31(3): 443-54, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21174144
3.
AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.
Clin Infect Dis
; 51(6): 668-77, 2010 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20687838
4.
Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks.
Health Secur
; 18(3): 241-249, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32348165
5.
Sustainable vaccine development: a vaccine manufacturer's perspective.
Curr Opin Immunol
; 53: 111-118, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29751212
6.
Towards an evidence based approach for the development of adjuvanted vaccines.
Curr Opin Immunol
; 47: 93-102, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28755542
7.
Comment on "CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy".
Sci Transl Med
; 6(242): 242le3, 2014 Jun 25.
Artigo
Inglês
| MEDLINE | ID: mdl-24964988
8.
Narcolepsy and A(H1N1)pdm09 vaccination: shaping the research on the observed signal.
Hum Vaccin Immunother
; 10(3): 572-6, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24342916
9.
Seeking help: B cells adapting to flu variability.
Sci Transl Med
; 6(246): 246ps8, 2014 Jul 23.
Artigo
Inglês
| MEDLINE | ID: mdl-25101885
10.
Short-term and mid-term solutions for influenza vaccines.
Lancet Infect Dis
; 18(8): 832-833, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30064669
11.
Long-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized study in adults aged 18-60 years and older.
Hum Vaccin Immunother
; 9(7): 1512-22, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23571166
12.
Effect on cellular and humoral immune responses of the AS03 adjuvant system in an A/H1N1/2009 influenza virus vaccine administered to adults during two randomized controlled trials.
Clin Vaccine Immunol
; 18(5): 835-43, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21450978
13.
Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets.
Vaccine
; 29(11): 2092-9, 2011 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-21237275
14.
Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.
Vaccine
; 29(11): 2120-6, 2011 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-21238573
15.
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
Vaccine
; 28(3): 849-57, 2010 Jan 08.
Artigo
Inglês
| MEDLINE | ID: mdl-19835828
16.
Retraction of the letter: "Comment on 'CD4⺠T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy' ".
Sci Transl Med
; 6(255): 255rt2, 2014 Sep 24.
Artigo
Inglês
| MEDLINE | ID: mdl-25253677
17.
Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine.
PLoS One
; 3(2): e1665, 2008 Feb 27.
Artigo
Inglês
| MEDLINE | ID: mdl-18301743
18.
A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses.
Influenza Other Respir Viruses
; 2(6): 251-60, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19453402
19.
Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vaccine
; 26(10): 1375-86, 2008 Mar 04.
Artigo
Inglês
| MEDLINE | ID: mdl-18272264
20.
Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine.
PLoS One
; 3(1): e1401, 2008 Jan 02.
Artigo
Inglês
| MEDLINE | ID: mdl-18167560